OncoDNA
OncoDNA’s aim is to provide medical innovations based on targeted sequencing or complete sequencing of tumour genomes, in order to assist medical doctors in their treatment choices and/or provide better monitoring of the evolution of patient tumors. The ambition of the newly created company is to “rapidly become a European reference for personalized analysis in oncology, based on the analysis of tumour’s DNA from patients.” said Jean-Pol Detiffe, founder and CEO of OncoDNA. “We will provide innovative analyses to private hospitals, research centres and also pharmaceutical clients”, he added.